# SWITCH: Study of the Prednisone to Dexamethasone Change in mCRPC Patients Treated With Abiraterone

> **NCT02928432** · PHASE2 · COMPLETED · sponsor: **Centro Nacional de Investigaciones Oncologicas CARLOS III** · enrollment: 26 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** Steroids switch

## Key facts

- **NCT ID:** NCT02928432
- **Lead sponsor:** Centro Nacional de Investigaciones Oncologicas CARLOS III
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06
- **Primary completion:** 2016-09
- **Final completion:** 2017-01
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2017-01-27

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02928432

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02928432, "SWITCH: Study of the Prednisone to Dexamethasone Change in mCRPC Patients Treated With Abiraterone". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02928432. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*